THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

James George to United States

This is a "connection" page, showing publications James George has written about United States.
Connection Strength

0.490
  1. Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial. Transfusion. 2017 10; 57(10):2532-2538.
    View in: PubMed
    Score: 0.094
  2. Long-term outcomes of health-related quality of life following diverse thrombotic microangiopathy syndromes. Am J Hematol. 2016 Jun; 91(4):E278-9.
    View in: PubMed
    Score: 0.088
  3. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol. 2010 Mar; 85(3):174-80.
    View in: PubMed
    Score: 0.057
  4. Letter to authors and readers regarding the new NIH policy on public access. Blood. 2005 May 15; 105(10):3767.
    View in: PubMed
    Score: 0.040
  5. Is immune thrombocytopenic purpura less common among black Americans? Blood. 2005 Feb 01; 105(3):1368-9.
    View in: PubMed
    Score: 0.040
  6. ASH Guideline Oversight Subcommittee Response to Jacobs et al regarding Industry Payments to ASH Guideline Panelists. Blood Adv. 2024 Jul 09; 8(13):3553-3554.
    View in: PubMed
    Score: 0.038
  7. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019 12 10; 3(23):3829-3866.
    View in: PubMed
    Score: 0.028
  8. The effect of an intense mentoring program on junior investigators' preparation for a patient-oriented clinical research career. Acad Med. 2015 Aug; 90(8):1061-6.
    View in: PubMed
    Score: 0.021
  9. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000.
    View in: PubMed
    Score: 0.021
  10. Health care utilization of patients diagnosed with idiopathic thrombotic thrombocytopenic purpura in a commercially insured population in the United States. Transfusion. 2012 Jul; 52(7 Pt 2):1614-21.
    View in: PubMed
    Score: 0.017
  11. Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood. 2010 Sep 23; 116(12):2127-33.
    View in: PubMed
    Score: 0.014
  12. Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially-insured population. Thromb Haemost. 2010 Jun; 103(6):1203-9.
    View in: PubMed
    Score: 0.014
  13. Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries. Am J Med. 2004 Jan 01; 116(1):28-34.
    View in: PubMed
    Score: 0.009
  14. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol. 2003 Feb; 25(2):130-3.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES